#de novo antibody design06/07/2025
Chai-2 AI Revolutionizes Antibody Design with 16% Success Rate in Zero-Shot Discovery
Chai Discovery Team's Chai-2 AI model achieves a 16% hit rate in zero-shot de novo antibody design, delivering validated binders for 50% of tested targets in under two weeks without large-scale screening.